Imclone lost its separate identity in 2014 when its former ImClone research and manufacturing sites were renamed as Eli Lilly and Company. ImClone's stock...

1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed...

Exchange Commission and U.S. Attorney probe into trading in the shares of ImClone Systems resulted in a widely publicized criminal case, which resulted in prison...

from 2005 to 2012. Stewart was convicted of felony charges related to the ImClone stock trading case; she served five months in federal prison for fraud...

was founded in 2009 by Samuel D. Waksal, founder and former CEO of ImClone Systems, a company now fully merged into Eli Lilly. Waksal had served a federal...

such as those affecting Enron, Tyco International, Adelphia, Peregrine Systems and WorldCom, when the concept was strongly emphasized in the Sarbanes–Oxley...

Memphis Grizzlies Samuel D. Waksal (1947–), French-born founder of ImClone Systems, Kadmon Corporation Herbert Wertheim (1939–), founder of eye care products...

Internet Icahn Enterprises conglomerates Iconix Brand Group fashion ImClone Systems pharmaceuticals ImpreMedia media Infor software Inner City Broadcasting...

Aventis/Imclone case" (PDF). Archived from the original (PDF) on 27 September 2011. Retrieved 25 May 2012. "Yeda Research v. Imclone Systems, et al"....

Rhythm Technologies, Inc. (acq. 1992) PCS System (acq. 1994) Icos Corporation (acq. 2007) Hypnion, Inc ImClone Systems SGX Pharmaceuticals, Inc (acq. 2008)...

factor receptor 2 (VEGFR2) antagonist. Ramucirumab was developed by ImClone Systems.[not verified in body] Ramucirumab is indicated for the treatment of...

with Samuel D. Waksal, the founder of the bio-pharmaceutical company ImClone Systems, who spent five years in federal prison for securities fraud. LaBeouf...

obstruction of justice, and lying to an FBI agent. She sold 3,928 shares of ImClone Systems, thereby avoiding a loss of $45,673. The next day, the Food and Drug...

Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. In October 2002, he pleaded guilty to charges of securities fraud...

experiment between the nervous systems of two humans. June 12 – The ImClone stock trading case begins when ImClone Systems CEO Samuel D. Waksal is arrested...

antibody for the treatment of solid tumors. This drug was developed by ImClone Systems, since acquired by Eli Lilly, using phage display technology from Dyax...

drug by the pharmaceutical company ImClone Systems, Inc. Paul Goldberg documented the missteps in FDA filings by ImClone that led to the failure to secure...

development was abandoned after phase I trials. Narnatumab was developed by ImClone Systems. "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab"...

Archived from the original on April 6, 2012. Retrieved November 1, 2011. "Ex-ImClone boss admits fraud". BBC News. October 15, 2002. Archived from the original...

Hachette Filipacchi Media U.S. Harden Furniture R.H. Hooper & Company ImClone Systems Kahr Arms Kaplan, Inc. Kaye Scholer KPMG Lehman Brothers Loehmann's...

designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials. "Statement On A Nonproprietary...

on his brother Lewis' legal career, especially Lewis' connection to ImClone Systems founder and former CEO Samuel D. Waksal, for ABC. Also on June 17,...

Nobel prize. However the dissimilarity between murine and human immune systems led to the clinical failure of these antibodies, except in some specific...

2006, he was the senior vice president, general counsel and CCO of ImClone Systems, a Nasdaq-100 biotechnology firm researching and developing cancer...

treatment of melanoma. It targets TYRP1. Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly. It was discontinued in 2012. "Statement On...

IMCL may refer to: Indian Made Country Liquor or Desi daru ImClone Systems This disambiguation page lists articles associated with the title IMCL. If...

included WorldCom Inc., Tyco International Ltd., Vivendi Universal SA and ImClone Systems Inc. In 2018, she won the Lifetime Achievement Award from the Gerald...

was CEO from February 2011 until February 2012, formerly employed by Imclone Systems. Savient declared bankruptcy in 2013. The drug was selling at $5,390...

biological half-life of 11 days. Olaratumab was originally developed by ImClone Systems, which was acquired by Eli Lilly in 2008. A Phase I clinical trial...

worldwide, apart from North America. (Cetuximab was discovered by Imclone Systems, and is marketed in North America by Bristol-Myers Squibb.) Other areas...